The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate ...

COVID-19 vaccine recommendations could be changing ... Forshee said one of the study’s limitations includes a “potential selection bias” for patients with more severe cases of myocarditis ...

Federal health agencies were alerted in February 2021 to "large reports of myocarditis" in young people who received the ...

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

Presented by The Coalition to Strengthen America’s Healthcare — The Trump administration on Tuesday said it plans to limit ...

The change was announced by the Food and Drug Administration, which falls under Health and Human Services. While Secretary ...

Invivyd plans to advance next generation COVID-19 mAbs to improve product scalability and system-friendliness while preserving strong anticipated mAb preventative efficacy; additional data on ...